A detailed history of Cetera Investment Advisers transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 20,689 shares of MIST stock, worth $37,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,689
Previous 17,427 18.72%
Holding current value
$37,033
Previous $31,000 12.9%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024

BUY
$1.29 - $1.83 $4,207 - $5,969
3,262 Added 18.72%
20,689 $27,000
Q1 2024

May 24, 2024

BUY
$1.4 - $2.2 $24,397 - $38,339
17,427 New
17,427 $31,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $53.7M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.